DGX
Quest Diagnostics Incorporated
NYSE: DGX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$194.20
+2.58% today
Updated 2026-04-30
Market cap
$20.96B
P/E ratio
20.92
P/S ratio
1.86x
EPS (TTM)
$9.05
Dividend yield
1.67%
52W range
$162 – $213
Volume
0.9M
Quest Diagnostics Incorporated (DGX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.27B | $6.70B | $7.25B | $7.46B | $7.37B | $7.51B | $7.38B | $7.15B | $7.43B | $7.49B | $7.51B | $7.71B | $7.53B | $7.73B | $9.44B | $10.79B | $9.88B | $9.25B | $9.87B | $11.04B |
| Revenue growth (YoY) | — | +7.0% | +8.1% | +2.8% | -1.2% | +1.9% | -1.7% | -3.2% | +4.0% | +0.8% | +0.3% | +2.6% | -2.3% | +2.6% | +22.1% | +14.3% | -8.4% | -6.4% | +6.7% | +11.8% |
| Cost of revenue | $3.70B | $3.97B | $4.26B | $4.32B | $4.32B | $4.40B | $4.36B | $4.33B | $4.64B | $4.66B | $4.62B | $4.72B | $4.93B | $5.04B | $5.80B | $6.58B | $6.45B | $6.20B | $6.63B | $7.51B |
| Gross profit | $2.57B | $2.74B | $2.99B | $3.13B | $3.05B | $3.12B | $3.02B | $2.82B | $2.80B | $2.84B | $2.90B | $2.99B | $2.60B | $2.69B | $3.63B | $4.21B | $3.43B | $3.05B | $3.24B | $3.52B |
| Gross margin | 41.0% | 40.8% | 41.3% | 42.0% | 41.4% | 41.5% | 40.9% | 39.5% | 37.6% | 37.8% | 38.6% | 38.8% | 34.6% | 34.8% | 38.5% | 39.0% | 34.7% | 33.0% | 32.9% | 31.9% |
| R&D | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| SG&A | $1.43B | $1.61B | $1.74B | $1.75B | $1.71B | $1.81B | $1.75B | $1.70B | $1.73B | $1.68B | $1.68B | $1.75B | $1.42B | $1.46B | $1.55B | $1.73B | $1.82B | $1.80B | $1.77B | $1.92B |
| Operating income | $1.13B | $1.09B | $1.22B | $1.36B | $1.30B | $995.00M | $1.20B | $1.48B | $983.00M | $1.40B | $1.28B | $1.17B | $1.10B | $1.23B | $1.97B | $2.38B | $1.43B | $1.26B | $1.35B | $1.60B |
| Operating margin | 18.0% | 16.3% | 16.9% | 18.2% | 17.6% | 13.2% | 16.3% | 20.6% | 13.2% | 18.7% | 17.0% | 15.1% | 14.6% | 15.9% | 20.9% | 22.1% | 14.4% | 13.6% | 13.6% | 14.5% |
| EBITDA | $1.33B | $1.33B | $1.50B | $1.63B | $1.59B | $1.30B | $1.52B | $1.79B | $1.30B | $1.55B | $1.48B | $1.45B | $1.40B | $1.58B | $2.41B | $3.16B | $1.82B | $1.26B | $1.89B | $2.19B |
| EBITDA margin | 21.1% | 19.8% | 20.7% | 21.9% | 21.5% | 17.3% | 20.6% | 25.1% | 17.5% | 20.8% | 19.7% | 18.8% | 18.6% | 20.5% | 25.5% | 29.3% | 18.4% | 13.6% | 19.2% | 19.9% |
| EBIT | $1.13B | $1.09B | $1.24B | $1.37B | $1.33B | $1.02B | $1.24B | $1.51B | $990.00M | $1.25B | $1.23B | $1.18B | $1.09B | $1.26B | $2.05B | $2.75B | $1.38B | $1.26B | $1.40B | $1.62B |
| Interest expense | $0.00 | $0.00 | $185.48M | $144.10M | $146.10M | $170.60M | $168.00M | $162.00M | $167.00M | $153.00M | $143.00M | $153.00M | $169.00M | $180.00M | $166.00M | $152.00M | $148.00M | $152.00M | $226.00M | $264.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $586.42M | $339.94M | $581.50M | $729.10M | $720.90M | $470.60M | $555.70M | $849.00M | $556.00M | $709.00M | $645.00M | $772.00M | $736.00M | $858.00M | $1.43B | $2.00B | $946.00M | $854.00M | $871.00M | $992.00M |
| Net income growth (YoY) | — | -42.0% | +71.1% | +25.4% | -1.1% | -34.7% | +18.1% | +52.8% | -34.5% | +27.5% | -9.0% | +19.7% | -4.7% | +16.6% | +66.8% | +39.4% | -52.6% | -9.7% | +2.0% | +13.9% |
| Profit margin | 9.4% | 5.1% | 8.0% | 9.8% | 9.8% | 6.3% | 7.5% | 11.9% | 7.5% | 9.5% | 8.6% | 10.0% | 9.8% | 11.1% | 15.2% | 18.5% | 9.6% | 9.2% | 8.8% | 9.0% |